Clinical Trial Update: Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating spironolactone and dexamethasone in hospitalized COVID-19 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Pneumonia Viral

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Spironolactone (spironolactone)

Snippet

Sponsor: Chita State Regional Clinical Hospital Number 1 | Conditions: Coronavirus Infection, Pneumonia, Viral | Phase 3 | Status: UNKNOWN